NEW YORK, July 9 (GenomeWeb News) - Jubilant Biosys has licensed its kinase small molecule database and its pathway database to the National Cancer Institute, the company said today.
The NCI took a license to Kinase ChemBioBase, a database of more than 190,000 small molecules covering over 300 kinase targets, and PathArt, a database that contains over 900 signaling and metabolic pathways curated manually from the literature.
Jubilant is based in Bangalore, India.